María Valeria Razori

María Valeria Razori

Auto-generated profile, based on publicly available information

María Valeria Razori

Instituto de Fisiología Experimental, Facultad de Ciencias Bioquímicas y Farmacéuticas, Universidad de Rosario, Argentina

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 October 2018 in Cellular and Molecular Life Sciences
Verified
Journal Article
Closed access
PDF file
FBFernando Bessone
Fernando Bessone
MRMaría Valeria Razori
María Valeria Razori
MRMarcelo Gabriel Roma
Marcelo Gabriel Roma

7 September 2018 in Alimentary Pharmacology & Therapeutics
Verified
Journal Article
Open access
PDF file
FBFernando Bessone
Fernando Bessone
MDMelisa Dirchwolf
Melisa Dirchwolf
MRMaría Agustina Rodil
María Agustina Rodil
MRMaría Valeria Razori
María Valeria Razori
MRMarcelo Gabriel Roma
Marcelo Gabriel Roma
Summary: Background: Nonalcoholic fatty disease (NAFLD) is the most common liver disease, since it is strongly associated with obesity and metabolic syndrome pandemics.NAFLDmay affect drug disposal and has common pathophysiological mechanisms with drug‐induced liver injury (DILI); this may predispose to hepatoxicity induced by certain drugs that share these pathophysiological mechanisms. In addition, drugs may trigger fatty liver and inflammationper seby mimickingNAFLDpathophysiological mechanisms.Aims: To provide a comprehensive update on (a) potential mechanisms whereby certain drugs can be more hepatotoxic inNAFLDpatients, (b) the steatogenic effects of drugs, and (c) the mechanism involved in drug‐induced steatohepatitis (DISH).Methods: A language‐ and date‐unrestricted Medline literature search was conducted to identify pertinent basic and clinical studies on the topic.Results: Drugs can induce macrovesicular steatosis by mimickingNAFLDpathogenic factors, including insulin resistance and imbalance between fat gain and loss. Other forms of hepatic fat accumulation exist, such as microvesicular steatosis and phospholipidosis, and are mostly associated with acute mitochondrial dysfunction and defective lipophagy, respectively. Drug‐induced mitochondrial dysfunction is also commonly involved in DISH. Patients with pre‐existingNAFLDmay be at higher risk ofDILIinduced by certain drugs, and polypharmacy in obese individuals to treat their comorbidities may be a contributing factor.Conclusions: The relationship betweenDILIandNAFLDmay be reciprocal: drugs can causeNAFLDby acting as steatogenic factors, and pre‐existingNAFLDcould be a predisposing condition for certain drugs to causeDILI. Polypharmacy associated with obesity might potentiate the association between this condition andDILI.

21 October 2014 in Journal of Experimental Botany
Verified
Journal Article
Open access
PDF file
MSMaría M. Scandiani
María M. Scandiani
ALAlicia G. Luque
Alicia G. Luque
MRMaría V. Razori
María V. Razori
LCLucila Ciancio Casalini
Lucila Ciancio Casalini
TATakayuki Aoki
Takayuki Aoki
CSClaudia P. Spampinato
Claudia P. Spampinato
Soybean germplasm exhibits various levels of resistance to Fusarium tucumaniae, the main causal agent of sudden death syndrome (SDS) of soybean in Argentina. In this study, two soybean genotypes, one susceptible (NA 4613) and one partially resistant (DM 4670) to SDS infection, were inoculated with F. tucumaniae. Disease symptoms were scored at 7, 10, 14, and 25 days post-inoculation (dpi). The greatest difference in the area under the disease progress curve (AUDPC) values among genotypes was observed at 25 dpi. In order to detect early metabolic markers that could potentially discriminate between susceptible and resistant genotypes, gas chromatography–mass spectrometry (GC-MS) analyses of root samples were performed. These analyses show higher levels of several amino acids and the polyamine cadaverine in the inoculated than in the uninoculated susceptible cultivar at 7 dpi. Principal component analysis (PCA) revealed that the metabolic profile of roots harvested at the earliest time points from the inoculated susceptible genotype was clearly differentiated from the rest of the samples. Furthermore, variables associated with the first principal component were mainly amino acids. Taken together, the results indicate that the pathogen induced the susceptible plant to accumulate amino acids in roots at early time points after infection, suggesting that GC-MS-based metabolomics could be used for the rapid characterization of cultivar response to SDS.

1 October 2019 in Biochemical Pharmacology
Verified
Journal Article
Closed access
MRMaría Valeria Razori
María Valeria Razori
PMPaula M. Maidagan
Paula M. Maidagan
NCNadia Ciriaci
Nadia Ciriaci
RARomina B. Andermatten
Romina B. Andermatten
Ismael Ricardo BarossoIsmael Ricardo Barosso
Ismael Ricardo Barosso
MRMarcelo Gabriel Roma
Marcelo Gabriel Roma

1 April 2020 in Biochemical Pharmacology
Verified
Journal Article
Closed access
SSSoraya Salas-Silva
Soraya Salas-Silva
ASArturo Simoni-Nieves
Arturo Simoni-Nieves
MRMaría Valeria Razori
María Valeria Razori
JLJocelyn López-Ramirez
Jocelyn López-Ramirez
Jonatan Barrera-ChimalJonatan Barrera-Chimal
Jonatan Barrera-Chimal
LBLeticia Bucio-Ortiz
Leticia Bucio-Ortiz

11 January 2019 in Clinical Science
Verified
Journal Article
Closed access
PDF file
PMPamela L. Martín
Pamela L. Martín
PCPaula Ceccatto
Paula Ceccatto
MRMaría V. Razori
María V. Razori
DFDaniel E.A. Francés
Daniel E.A. Francés
SASandra M.M. Arriaga
Sandra M.M. Arriaga
CBCecilia L Basiglio
Cecilia L Basiglio
We previously demonstrated in in vitro and ex vivo models that physiological concentrations of unconjugated bilirubin (BR) prevent oxidative stress (OS)-induced hepatocanalicular dysfunction and cholestasis. Here, we aimed to ascertain, in the whole rat, whether a similar cholestatic OS injury can be counteracted by heme oxygenase-1 (HO-1) induction that consequently elevates endogenous BR levels. This was achieved through the administration of hemin, an inducer of HO-1, the rate-limiting step in BR generation. We found that BR peaked between 6 and 8 h after hemin administration. During this time period, HO-1 induction fully prevented the pro-oxidant tert-butylhydroperoxide (tBuOOH)-induced drop in bile flow, and in the biliary excretion of bile salts and glutathione, the two main driving forces of bile flow; this was associated with preservation of the membrane localization of their respective canalicular transporters, bile salt export pump (Bsep) and multidrug resistance-associated protein 2 (Mrp2), which are otherwise endocytosed by OS. HO-1 induction counteracted the oxidation of intracellular proteins and membrane lipids induced by tBuOOH, and fully prevented the increase in the oxidized-to-total glutathione (GSHt) ratio, a sensitive parameter of hepatocellular OS. Compensatory elevations of the activity of the antioxidant enzymes catalase (CAT) and superoxide dismutase (SOD) were also prevented. We conclude that in vivo HO-1 induction protects the liver from acute oxidative injury, thus preventing consequent cholestasis. This reveals an important role for the induction of HO-1 and the consequently elevated levels of BR in preserving biliary secretory function under OS conditions, thus representing a novel therapeutic tool to limit the cholestatic injury that bears an oxidative background.